Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Goodwill - Additional Information (Details)

v3.24.0.1
Goodwill - Additional Information (Details)
€ in Thousands
 12 Months Ended
Dec. 31, 2023
EUR (€)
Dec. 31, 2022
Unit
Disclosure Of Reconciliation Of Changes In Goodwill [Line Items]    
Number of Cash-generating Unit   3
Growth rate 1.00%  
Bottom of Range    
Disclosure Of Reconciliation Of Changes In Goodwill [Line Items]    
Growth rate 0.00%  
Percentage of average contraction of EBITDA at continuing value (20.00%)  
Top of Range    
Disclosure Of Reconciliation Of Changes In Goodwill [Line Items]    
Growth rate 3.00%  
Percentage of average contraction of EBITDA at continuing value 20.00%  
Biopharmaceutical and Diagnostic Solutions    
Disclosure Of Reconciliation Of Changes In Goodwill [Line Items]    
Number of Cash-generating Unit   2
Engineering    
Disclosure Of Reconciliation Of Changes In Goodwill [Line Items]    
Number of Cash-generating Unit   1
Biopharmaceutical and Diagnostic Solutions    
Disclosure Of Reconciliation Of Changes In Goodwill [Line Items]    
Discount rate 7.70%  
Percentage of average contraction of EBITDA at continuing value 63.40%  
Biopharmaceutical and Diagnostic Solutions | Bottom of Range    
Disclosure Of Reconciliation Of Changes In Goodwill [Line Items]    
Discount rate 6.70%  
Biopharmaceutical and Diagnostic Solutions | Top of Range    
Disclosure Of Reconciliation Of Changes In Goodwill [Line Items]    
Discount rate 8.70%  
Biopharmaceutical and Diagnostic Solutions | Weighted Average Cost of Capital, Measurement Input    
Disclosure Of Reconciliation Of Changes In Goodwill [Line Items]    
Further sensitivity analysis resulted in identification of breakeven 19.40%  
Engineering Systems    
Disclosure Of Reconciliation Of Changes In Goodwill [Line Items]    
Change in consideration on acquisition | € € 2,740  
Discount rate 7.50% 8.80%
Percentage of average contraction of EBITDA at continuing value 97.80%  
Engineering Systems | Bottom of Range    
Disclosure Of Reconciliation Of Changes In Goodwill [Line Items]    
Discount rate 6.50%  
Engineering Systems | Top of Range    
Disclosure Of Reconciliation Of Changes In Goodwill [Line Items]    
Discount rate 8.50%  
Engineering Systems | Weighted Average Cost of Capital, Measurement Input    
Disclosure Of Reconciliation Of Changes In Goodwill [Line Items]    
Discount rate 7.50%  
Further sensitivity analysis resulted in identification of breakeven 22.10%  
Percentage of average contraction of EBITDA at continuing value 11.20%  
DCS and IVD & DDS    
Disclosure Of Reconciliation Of Changes In Goodwill [Line Items]    
Discount rate   8.60%
Percentage of average contraction of EBITDA at continuing value 36.20%  
DCS and IVD & DDS | Weighted Average Cost of Capital, Measurement Input    
Disclosure Of Reconciliation Of Changes In Goodwill [Line Items]    
Discount rate 7.70%  
Drug Containment Systems    
Disclosure Of Reconciliation Of Changes In Goodwill [Line Items]    
Percentage of average contraction of EBITDA at continuing value 65.40%  
Drug Containment Systems | Weighted Average Cost of Capital, Measurement Input    
Disclosure Of Reconciliation Of Changes In Goodwill [Line Items]    
Further sensitivity analysis resulted in identification of breakeven 20.40%